Moleculin Biotech grants CFO Jonathan Foster 260,000 stock options and 260,000 restricted stock units
Moleculin Biotech granted Chief Financial Officer Jonathan P. Foster 260,000 stock options on October 15, 2026. Foster also received 260,000 restricted stock units on the same date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to prov